Director of the Institute for Sport Business and Associate Dean for Enterprise at Loughborough University
Not Clearly Pro or Con to the question "Should Performance Enhancing Drugs (Such as Steroids) Be Accepted in Sports?"
"Although the use of banned drugs in sport is not a new phenomenon, little is known about the experiences and perceptions of athletes who have committed anti-doping rule violations... When explaining their decision to dope, athletes engaged in processes or moral disengagement (including advantageous comparison, minimizing consequences and diffusion of responsibility). Ironically, moral arguments were perceived as the most effective deterrents to doping."
Cowritten with Stephen Moston and Terry Engelberg, "The Final Frontier of Anti-Doping: A Study of Athletes Who Have Committed Doping Violations," Sport Management Review, Aug. 2015
Experts Individuals with MDs, JDs, PhDs, or equivalent advanced degrees in fields relevant to performance enhancing drugs and sports. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to performance enhancing drugs and sports.
Involvement and Affiliations:
Director, Institute for Sport Business, Loughborough University (London), July 2014-present
Associate Dean, Enterprise, Loughborough University (London), July 2014-present
Visiting Professor, Beijing Sport University
Visiting Professor, Russian Olympic University
Department Head, Tourism, Leisure, Hotel and Sport Management, Griffith Business School, Griffith University (Australia), June 2003-June 2014
Professor, Griffith Business School, Griffith University, June 2003-June 2014
Lecturer in Sport Management, Southern Cross University, June 1999–June 2003
PhD, Organisational Leadership, Culture and Strategic Change, Victoria University, 2001
MBA, Bond University, 1993
BA, Physical Education, Queensland University of Technology, 1991